mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.02 |